Peter Hovind

Medicin og biovidenskab

1. Diabetic Nephropathies 100%
2. Type 1 Diabetes Mellitus 70%
3. Albuminuria 42%
4. Glomerular Filtration Rate 38%
5. Blood Pressure 31%
6. Irbesartan 29%
7. Type 2 Diabetes Mellitus 23%
8. Kidney 23%
9. Sarcopenia 18%
10. Vitamin D 18%
11. Albumins 18%
12. Edetic Acid 17%
13. Chronic Kidney Failure 15%
14. Biomarkers 15%
15. Uric Acid 14%
16. Mannose-Binding Lectin 13%
17. Renin-Angiotensin System 12%
18. Cohort Studies 11%
19. Placebos 11%
20. Inflammation 11%
21. Glucagon-Like Peptide 1 11%
22. Lung Transplantation 11%
23. Angiotensin Receptor Antagonists 11%
24. Serum 10%
25. Metformin 10%
26. Mortality 10%
27. C-Reactive Protein 9%
28. Arterial Pressure 9%
29. Bone Density 9%
30. Advanced Glycation End Products 9%
31. 3-deoxyglucosone 8%
32. Young Adult 8%
33. Creatinine 8%
34. Smoking 8%
35. Hypertension 8%
36. Therapeutics 7%
37. Tilt-Table Test 7%
38. ficolin 7%
39. Antihypertensive Agents 7%
40. Glyoxal 7%
41. N(6)-carboxymethyllysine 7%
42. Orthostatic Intolerance 7%
43. Walking Speed 7%
44. Glucagon-Like Peptide-1 Receptor 7%
45. Randomized Controlled Trials 7%
46. Glucose 7%
47. Mannose-Binding Protein-Associated Serine Proteases 7%
48. Survival 6%
49. Pyruvaldehyde 6%
50. Liraglutide 6%